Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity

Jordi Riba, Ulrike M. Krämer, Marcus Heldmann et al. · 2008

Read Dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity by Jordi Riba, Ulrike M. Krämer, Marcus Heldmann et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002479.txt.

Description

Riba led the team behind a 2008 research article in PLOS ONE. Named on the byline are Jordi Riba, Ulrike M. Krämer, Marcus Heldmann, among others. Its subject is dopamine Agonist Increases Risk Taking but Blunts Reward-Related Brain Activity. The use of D2/D3 dopaminergic agonists in Parkinson's disease (PD) may lead to pathological gambling.

The authors lay out their aims in clear terms and keep the focus on the work itself. In short, the piece gives a clear, short route into a field that can seem hard to enter from the outside. PLOS ONE is an open journal, and the full text can be read free by anyone who wants to check the work.

Catalog record

CREATORJordi Riba, Ulrike M. Krämer, Marcus Heldmann et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002479

Browse the full library · About the Tower of Babel